TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth

miR-155 is an oncogenic microRNA which is upregulated in many solid cancers. The targets of miR-155 are well established , with over 100 confirmed mRNA targets. However, the regulation of miR-155 and the basis of its upregulation in cancer is not well understood. We have previously shown that miR-15...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget 2013-11, Vol.4 (11), p.1894-1903
Hauptverfasser: Mattiske, Sam, Ho, Kristen, Noll, Jacqueline E, Neilsen, Paul M, Callen, David F, Suetani, Rachel J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1903
container_issue 11
container_start_page 1894
container_title Oncotarget
container_volume 4
creator Mattiske, Sam
Ho, Kristen
Noll, Jacqueline E
Neilsen, Paul M
Callen, David F
Suetani, Rachel J
description miR-155 is an oncogenic microRNA which is upregulated in many solid cancers. The targets of miR-155 are well established , with over 100 confirmed mRNA targets. However, the regulation of miR-155 and the basis of its upregulation in cancer is not well understood. We have previously shown that miR-155 is regulated by p63, and here we investigate the role of the major p63 isoforms TAp63 and ΔNp63 in this regulation. When the TAp63 isoform was knocked down, or exogenously overexpressed, miR-155 levels were elevated in response to TAp63 knockdown or reduced in response to TAp63 overexpression. The ΔNp63 isoform is shown to directly bind to the p63 response element on the miR-155 host gene, and this binding is enriched when TAp63 is knocked down. This could indicate that TAp63 prevents ΔNp63 from binding to the miR-155 host gene. The knockdown of TAp63, and the subsequent elevation of miR-155, enhances migration and tumour growth similar to that seen when directly overexpressing miR-155. The migratory phenotype is abrogated when miR-155 is inhibited, indicating that miR-155 is responsible for the phenotypic effect of TAp63 knockdown.
doi_str_mv 10.18632/oncotarget.1228
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3875757</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1464494909</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-c43e40994fa59831f153f7731fe362d18a7f3057e55be8a30403adf42871d843</originalsourceid><addsrcrecordid>eNpVUU1PwzAMjRCITWN3TqhHLh35bJIL0jTxJU1CQrtHWZt2QW0zkhTEvyewMYZ9sGX7PVt-AFwiOEOiIPjG9aWL2jcmzhDG4gSMkaQyx4yR06N8BKYhvMJkjHKB5TkYYYo4RwUfg8fVfFuQzJtmaHU0IfsmbUxvy6yzLzliLIsu60xlUzeVGq-jdX2m-yqLQ-cGnzXefcTNBTirdRvMdB8nYHV_t1o85svnh6fFfJmXRBYxLykxFEpJa82kIKhGjNScp8SQAldIaF4TyLhhbG2EJpBCoquaYsFRJSiZgNsd7XZYp6tK00evW7X1ttP-Uzlt1f9Obzeqce-KCM6SJ4LrPYF3b4MJUXU2lKZtdW_cEBSiBaXpdVCmUbgbLb0LwZv6sAZB9SOB-pNAfUuQIFfH5x0Avw8nX6OZhHY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1464494909</pqid></control><display><type>article</type><title>TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free E- Journals</source><source>PubMed Central Open Access</source><creator>Mattiske, Sam ; Ho, Kristen ; Noll, Jacqueline E ; Neilsen, Paul M ; Callen, David F ; Suetani, Rachel J</creator><creatorcontrib>Mattiske, Sam ; Ho, Kristen ; Noll, Jacqueline E ; Neilsen, Paul M ; Callen, David F ; Suetani, Rachel J</creatorcontrib><description>miR-155 is an oncogenic microRNA which is upregulated in many solid cancers. The targets of miR-155 are well established , with over 100 confirmed mRNA targets. However, the regulation of miR-155 and the basis of its upregulation in cancer is not well understood. We have previously shown that miR-155 is regulated by p63, and here we investigate the role of the major p63 isoforms TAp63 and ΔNp63 in this regulation. When the TAp63 isoform was knocked down, or exogenously overexpressed, miR-155 levels were elevated in response to TAp63 knockdown or reduced in response to TAp63 overexpression. The ΔNp63 isoform is shown to directly bind to the p63 response element on the miR-155 host gene, and this binding is enriched when TAp63 is knocked down. This could indicate that TAp63 prevents ΔNp63 from binding to the miR-155 host gene. The knockdown of TAp63, and the subsequent elevation of miR-155, enhances migration and tumour growth similar to that seen when directly overexpressing miR-155. The migratory phenotype is abrogated when miR-155 is inhibited, indicating that miR-155 is responsible for the phenotypic effect of TAp63 knockdown.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.1228</identifier><identifier>PMID: 24177167</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Animals ; Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Cell Movement - physiology ; Female ; Gene Expression Regulation, Neoplastic ; Gene Knockdown Techniques ; Heterografts ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; MicroRNAs - antagonists &amp; inhibitors ; MicroRNAs - biosynthesis ; MicroRNAs - genetics ; MicroRNAs - metabolism ; Research Paper ; Transcription Factors - biosynthesis ; Transcription Factors - genetics ; Transcription Factors - metabolism ; Tumor Suppressor Proteins - biosynthesis ; Tumor Suppressor Proteins - genetics ; Tumor Suppressor Proteins - metabolism ; Up-Regulation</subject><ispartof>Oncotarget, 2013-11, Vol.4 (11), p.1894-1903</ispartof><rights>Copyright: © 2013 Mattiske et al. 2013</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-c43e40994fa59831f153f7731fe362d18a7f3057e55be8a30403adf42871d843</citedby><cites>FETCH-LOGICAL-c396t-c43e40994fa59831f153f7731fe362d18a7f3057e55be8a30403adf42871d843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875757/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875757/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24177167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mattiske, Sam</creatorcontrib><creatorcontrib>Ho, Kristen</creatorcontrib><creatorcontrib>Noll, Jacqueline E</creatorcontrib><creatorcontrib>Neilsen, Paul M</creatorcontrib><creatorcontrib>Callen, David F</creatorcontrib><creatorcontrib>Suetani, Rachel J</creatorcontrib><title>TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>miR-155 is an oncogenic microRNA which is upregulated in many solid cancers. The targets of miR-155 are well established , with over 100 confirmed mRNA targets. However, the regulation of miR-155 and the basis of its upregulation in cancer is not well understood. We have previously shown that miR-155 is regulated by p63, and here we investigate the role of the major p63 isoforms TAp63 and ΔNp63 in this regulation. When the TAp63 isoform was knocked down, or exogenously overexpressed, miR-155 levels were elevated in response to TAp63 knockdown or reduced in response to TAp63 overexpression. The ΔNp63 isoform is shown to directly bind to the p63 response element on the miR-155 host gene, and this binding is enriched when TAp63 is knocked down. This could indicate that TAp63 prevents ΔNp63 from binding to the miR-155 host gene. The knockdown of TAp63, and the subsequent elevation of miR-155, enhances migration and tumour growth similar to that seen when directly overexpressing miR-155. The migratory phenotype is abrogated when miR-155 is inhibited, indicating that miR-155 is responsible for the phenotypic effect of TAp63 knockdown.</description><subject>Animals</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Cell Movement - physiology</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gene Knockdown Techniques</subject><subject>Heterografts</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Nude</subject><subject>MicroRNAs - antagonists &amp; inhibitors</subject><subject>MicroRNAs - biosynthesis</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>Research Paper</subject><subject>Transcription Factors - biosynthesis</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><subject>Tumor Suppressor Proteins - biosynthesis</subject><subject>Tumor Suppressor Proteins - genetics</subject><subject>Tumor Suppressor Proteins - metabolism</subject><subject>Up-Regulation</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1PwzAMjRCITWN3TqhHLh35bJIL0jTxJU1CQrtHWZt2QW0zkhTEvyewMYZ9sGX7PVt-AFwiOEOiIPjG9aWL2jcmzhDG4gSMkaQyx4yR06N8BKYhvMJkjHKB5TkYYYo4RwUfg8fVfFuQzJtmaHU0IfsmbUxvy6yzLzliLIsu60xlUzeVGq-jdX2m-yqLQ-cGnzXefcTNBTirdRvMdB8nYHV_t1o85svnh6fFfJmXRBYxLykxFEpJa82kIKhGjNScp8SQAldIaF4TyLhhbG2EJpBCoquaYsFRJSiZgNsd7XZYp6tK00evW7X1ttP-Uzlt1f9Obzeqce-KCM6SJ4LrPYF3b4MJUXU2lKZtdW_cEBSiBaXpdVCmUbgbLb0LwZv6sAZB9SOB-pNAfUuQIFfH5x0Avw8nX6OZhHY</recordid><startdate>20131101</startdate><enddate>20131101</enddate><creator>Mattiske, Sam</creator><creator>Ho, Kristen</creator><creator>Noll, Jacqueline E</creator><creator>Neilsen, Paul M</creator><creator>Callen, David F</creator><creator>Suetani, Rachel J</creator><general>Impact Journals LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131101</creationdate><title>TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth</title><author>Mattiske, Sam ; Ho, Kristen ; Noll, Jacqueline E ; Neilsen, Paul M ; Callen, David F ; Suetani, Rachel J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-c43e40994fa59831f153f7731fe362d18a7f3057e55be8a30403adf42871d843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Cell Movement - physiology</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gene Knockdown Techniques</topic><topic>Heterografts</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Nude</topic><topic>MicroRNAs - antagonists &amp; inhibitors</topic><topic>MicroRNAs - biosynthesis</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>Research Paper</topic><topic>Transcription Factors - biosynthesis</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><topic>Tumor Suppressor Proteins - biosynthesis</topic><topic>Tumor Suppressor Proteins - genetics</topic><topic>Tumor Suppressor Proteins - metabolism</topic><topic>Up-Regulation</topic><toplevel>online_resources</toplevel><creatorcontrib>Mattiske, Sam</creatorcontrib><creatorcontrib>Ho, Kristen</creatorcontrib><creatorcontrib>Noll, Jacqueline E</creatorcontrib><creatorcontrib>Neilsen, Paul M</creatorcontrib><creatorcontrib>Callen, David F</creatorcontrib><creatorcontrib>Suetani, Rachel J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mattiske, Sam</au><au>Ho, Kristen</au><au>Noll, Jacqueline E</au><au>Neilsen, Paul M</au><au>Callen, David F</au><au>Suetani, Rachel J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2013-11-01</date><risdate>2013</risdate><volume>4</volume><issue>11</issue><spage>1894</spage><epage>1903</epage><pages>1894-1903</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>miR-155 is an oncogenic microRNA which is upregulated in many solid cancers. The targets of miR-155 are well established , with over 100 confirmed mRNA targets. However, the regulation of miR-155 and the basis of its upregulation in cancer is not well understood. We have previously shown that miR-155 is regulated by p63, and here we investigate the role of the major p63 isoforms TAp63 and ΔNp63 in this regulation. When the TAp63 isoform was knocked down, or exogenously overexpressed, miR-155 levels were elevated in response to TAp63 knockdown or reduced in response to TAp63 overexpression. The ΔNp63 isoform is shown to directly bind to the p63 response element on the miR-155 host gene, and this binding is enriched when TAp63 is knocked down. This could indicate that TAp63 prevents ΔNp63 from binding to the miR-155 host gene. The knockdown of TAp63, and the subsequent elevation of miR-155, enhances migration and tumour growth similar to that seen when directly overexpressing miR-155. The migratory phenotype is abrogated when miR-155 is inhibited, indicating that miR-155 is responsible for the phenotypic effect of TAp63 knockdown.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>24177167</pmid><doi>10.18632/oncotarget.1228</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof Oncotarget, 2013-11, Vol.4 (11), p.1894-1903
issn 1949-2553
1949-2553
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3875757
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free E- Journals; PubMed Central Open Access
subjects Animals
Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Cell Movement - physiology
Female
Gene Expression Regulation, Neoplastic
Gene Knockdown Techniques
Heterografts
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
MicroRNAs - antagonists & inhibitors
MicroRNAs - biosynthesis
MicroRNAs - genetics
MicroRNAs - metabolism
Research Paper
Transcription Factors - biosynthesis
Transcription Factors - genetics
Transcription Factors - metabolism
Tumor Suppressor Proteins - biosynthesis
Tumor Suppressor Proteins - genetics
Tumor Suppressor Proteins - metabolism
Up-Regulation
title TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A23%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TAp63%20regulates%20oncogenic%20miR-155%20to%20mediate%20migration%20and%20tumour%20growth&rft.jtitle=Oncotarget&rft.au=Mattiske,%20Sam&rft.date=2013-11-01&rft.volume=4&rft.issue=11&rft.spage=1894&rft.epage=1903&rft.pages=1894-1903&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.1228&rft_dat=%3Cproquest_pubme%3E1464494909%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1464494909&rft_id=info:pmid/24177167&rfr_iscdi=true